Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for prevention of succinylcholine-induced myalgia in outpatient surgery
IRCT2014062412789N5Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences (Vice Chancellor for Research)
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine in myalgia, sponsored by Kurdistan University of Medical Sciences (Vice Chancellor for Research). Started Nov 2013; status: completed.
02
Drugs
ketamine
03
Conditions
myalgia
Beyond the preview
Go deeper on IRCT2014062412789N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014062412789N5.